Factor Therapeutics Limited
Records under this name other than patents Factor Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Factor Therapeutics Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,090,706 | Fibronectin: growth factor chimeras Lapsed on the fee record Ended Jul 28, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 28, 2023 | From the USPTO record |
| US 8,871,709 | Synthetic Chimeric Proteins Comprising Epidermal Growth Factor and Vitronectin Lapsed on the fee record Ended Oct 28, 2022 · Medium confidence | Lapsed on the fee record | Ended Oct 28, 2022 | Medium confidence |
| US 10,106,582 | Complex-formation-modulating agents and uses therefor Lapsed on the fee record Ended Oct 23, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 23, 2022 | From the USPTO record |
| US 7,785,835 | Methods of producing growth factor complex Lapsed on the fee record Ended Aug 31, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 31, 2022 | From the USPTO record |
| US 7,659,367 | Growth factor complexes and modulation of cell migration and growth Lapsed on the fee record Ended Feb 9, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 9, 2022 | From the USPTO record |
| US 8,563,507 | Method of treating a disease or condition characterized by aberrant epithelial cell proliferation Term ended Term ended Sep 24, 2021 · From the USPTO record | Term ended | Term ended Sep 24, 2021 | From the USPTO record |
| US 8,933,027 | Method of treating a disease or condition characterised by aberrant epithelial cell proliferation Term ended Ended no later than Sep 24, 2021 · From the USPTO record | Term ended | Ended no later than Sep 24, 2021 | From the USPTO record |
| US 7,514,398 | Growth factor complex Lapsed on the fee record Ended Apr 7, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 7, 2021 | From the USPTO record |
| US 9,562,086 | Vitronectin:Keratinocyte Growth Factor Chimeras Lapsed on the fee record Ended Feb 7, 2021 · Medium confidence | Lapsed on the fee record | Ended Feb 7, 2021 | Medium confidence |